Back to Atlas
CTransientStandard research/education caution
CMP-0307
Supplement/food-derived
Daidzein
Phyto-SERM / Nutraceutical
Bone, vascular, menopausal and endocrine-modulating nutraceutical positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Isoflavone
- Primary mechanism
- Weak ERβ-preferring phytoestrogen and gut-metabolite precursor
- Primary market use
- Phytoestrogen / menopause
Pharmacology
- Molecular weight (Da)
- 254.24
- Oral bioavailability
- Oral; variable by microbiome
- Half-life
- ~6-8 h
- Route tags
- Route-dependent / verify
- Evidence level
- Human/supplement research
- Clinical status
- Supplement/food-derived
- Value-for-money score
- 5 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Low-risk nutraceutical category; effect depends strongly on microbiome/equol production